ABBOTT PARK, Ill., May 3, 2018 — Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) clearance of the Advisor™ HD Grid Mapping Catheter, Sensor Enabled™. Advisor HD Grid employs a new design that allows physicians to see things differently, capturing and analyzing data in a novel manner to create highly detailed maps of the heart that better differentiate healthy from unhealthy tissue.

After previously saying she had secured a commitment to pass the legislation by the end of 2017, Sen. Susan Collins, R-Maine, said bills to fund the Affordable Care Act (ACA)'s cost-sharing reduction subsidies and provide $5 billion in reinsurance will be left out of a year-end spending package.